10-year-old Sully Mettille, once critically ill, is now thriving and representing this year’s Variety Kids Telethon as ...

ACI-7104 Phase 2 data and mid-2026 readout, plus FY25 cash burn and dilution risk—see key catalysts and what to do now.

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class ...

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) introduced a new resource to Pennsylvania courts on Friday, March 20, entitled Narcan in Courts. According to information from DDAP, the ...

AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate UpdatePhase 2 interim results suggest treatment with active ...

MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today ...

College wrestling coaches and athletes discuss how NIL and the transfer portal are transforming the sport, from contracts to ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well ...

Prime Minister Benjamin Netanyahu says an attack against Iran was urgently necessary because Iran was building new underground sites to shield its missile and nuclear programs from attacks. “The ...

Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, announces that it has secured exclusive and non-exclusive licenses to key ...

Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed. For years, mitochondrial ...

New UAB research uncovers how NFAT helps uterine NK cells support early placenta development, shedding light on pregnancy health and the roots of complications like preeclampsia.